TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $836K invested in Theriva Biologics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

10% less capital invested

Capital invested by funds: $932K → $836K (-$96K)

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.37M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.6K
2
+$25K
3
+$21K
4
UBS Group
UBS Group
Switzerland
+$11.8K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.6K

Top Sellers

1
-$31K
2
-$453
3
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$379K
2
$228K
3
$48K
4
$30K
5
$27K
6
$24K
7
$21K
8
$19K
9
$17K
10
$12K
11
$11K
12
$8K
13
$8K
14
$2K
15
$1K
16
$1K
17
–